Abstract | BACKGROUND:
Amiodarone is a highly effective treatment for supraventricular and ventricular tachyarrhythmia; however, it could be associated with several serious adverse effects, including liver injury. CASE PRESENTATION: We report the clinical and histological features of two contrasting Japanese patients with amiodarone-induced reversible and irreversible hepatotoxicity. One patient with amiodarone-induced irreversible hepatotoxicity showed liver cirrhosis during treatment with amiodarone and died of hepatic failure; the other patient, who had reversible hepatotoxicity, showed a reversible course of liver function and imaging after discontinuation of amiodarone. CONCLUSIONS: We emphasize the importance of close monitoring of liver enzymes and evaluation of liver computed tomographic imaging as well as liver biopsy during treatment with amiodarone, and discontinuation should be considered when amiodarone-induced hepatotoxicity is suspected.
|
Authors | Toyonobu Tsuda, Hayato Tada, Yoshihiro Tanaka, Naoto Nishida, Taiji Yoshida, Takeshi Sawada, Kenji Sakata, Kenshi Hayashi, Masa-Aki Kawashiri, Takeru Oyama, Motoko Sasaki, Nozomu Kurose, Masakazu Yamagishi |
Journal | Journal of medical case reports
(J Med Case Rep)
Vol. 12
Issue 1
Pg. 95
(Apr 14 2018)
ISSN: 1752-1947 [Electronic] England |
PMID | 29653592
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Anti-Arrhythmia Agents
- Aspartate Aminotransferases
- Alanine Transaminase
- Amiodarone
|
Topics |
- Aged
- Alanine Transaminase
(blood)
- Amiodarone
(adverse effects, blood)
- Anti-Arrhythmia Agents
(adverse effects, blood)
- Aspartate Aminotransferases
(blood)
- Chemical and Drug Induced Liver Injury
(diagnosis)
- Fatal Outcome
- Humans
- Liver Cirrhosis
(chemically induced, diagnostic imaging)
- Liver Function Tests
- Male
- Non-alcoholic Fatty Liver Disease
(chemically induced, diagnostic imaging)
- Tachycardia, Ventricular
(drug therapy)
- Tomography, X-Ray Computed
|